Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LILRA3 Antikörper (AA 219-438)

LILRA3 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1859662
  • Target Alle LILRA3 Antikörper anzeigen
    LILRA3 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (Without TM Domain), Member 3 (LILRA3))
    Bindungsspezifität
    • 6
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 219-438
    Reaktivität
    • 24
    • 1
    • 1
    • 1
    Human
    Wirt
    • 18
    • 6
    Kaninchen
    Klonalität
    • 20
    • 4
    Polyklonal
    Konjugat
    • 17
    • 3
    • 1
    • 1
    • 1
    • 1
    Dieser LILRA3 Antikörper ist unkonjugiert
    Applikation
    • 16
    • 8
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    Polyclonal Antibody to Leukocyte Immunoglobulin Like Receptor Subfamily A, Member 3 (LILRA3)
    Spezifität
    The antibody is a rabbit polyclonal antibody raised against LILRA3. It has been selected for its ability to recognize LILRA3 in immunohistochemical staining and western blotting.
    Aufreinigung
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogen
    Recombinant Leukocyte Immunoglobulin Like Receptor Subfamily A, Member 3 (LILRA3) corresdonding to Val219~Gly438 (Accession # Q8N6C8)
    Isotyp
    IgG
    Top Product
    Discover our top product LILRA3 Primärantikörper
  • Applikationshinweise

    Western blotting: 0.5-2 μg/mL Immunocytochemistry in formalin fixed cells: 5-20 μg/mL Immunohistochemistry in formalin fixed frozen section: 5-20 μg/mL Immunohistochemistry in paraffin section: 5-20 μg/mL Enzyme-linked Immunosorbent Assay: 0.05-2 μg/mL Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    24 months
  • Target
    LILRA3 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (Without TM Domain), Member 3 (LILRA3))
    Andere Bezeichnung
    Leukocyte Immunoglobulin Like Receptor Subfamily A, Member 3 (LILRA3 Produkte)
    Synonyme
    CD85E antikoerper, HM31 antikoerper, HM43 antikoerper, ILT-6 antikoerper, ILT6 antikoerper, LIR-4 antikoerper, LIR4 antikoerper, e3 antikoerper, leukocyte immunoglobulin like receptor A3 antikoerper, LILRA3 antikoerper
    Hintergrund
    CD85e, HM31, HM43, ILT6, LIR4, E3, CD85 antigen-like family member E, Immunoglobulin-like transcript 6, Leukocyte immunoglobulin-like receptor 4
Sie sind hier:
Kundenservice